Speakers

Christian Grimm

Christian
Grimm

Pharmacology & Toxicology, Ludwig-Maximilians Universität München, DE
Christian
Grimm
Dominic  Grün

Dominic
Grün

Max Planck Institute of Immunology and Epigenetics, DE
Dominic
Grün
Caroline Gutjahr

Caroline
Gutjahr

Max Planck Institute of Molecular Plant Physiology, DE
Caroline
Gutjahr
Naomi  Habib

Naomi
Habib

The Hebrew University of Jerusalem, Center for Brain Sciences, IL
Naomi
Habib
David  Hackam

David
Hackam

Johns Hopkins University School of Medicine, Baltimore, US
David
Hackam
James Hadfield

James
Hadfield

Senior Director (Epigenomics) Translational Medicine, R&D Oncology, AstraZeneca, UK
James
Hadfield
Georg Halder

Georg
Halder

VIB - KU Leuven Center for cancer Biology, BE
Georg
Halder
Hamida Hammad

Hamida
Hammad

VIB-UGent Center for Inflammation Research, BE
Hamida
Hammad
Bonnie Hammer

Bonnie
Hammer

Vice President of Biologics Development, Invenra, US
Bonnie
Hammer
Cara Haney

Cara
Haney

The University of British Columbia, CA
Cara
Haney
Alexandre Harari

Alexandre
Harari

Department of oncology UNIL CHUV Ludwig Institute for Cancer Research Lausanne, CH
Alexandre
Harari